Central and Peripheral Nervous System Correlates of Difficulty Discarding in Hoarding Disorder

中枢和周围神经系统与囤积症中丢弃困难的相关性

基本信息

  • 批准号:
    9917103
  • 负责人:
  • 金额:
    $ 21.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-25 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

There is a critical gap in our understanding of the underlying neurobiological mechanisms of difficulty discarding, the core behavioral feature of hoarding disorder (HD). This gap represents an important problem because, until it is filled, the field will not be able to precisely identify mechanistic targets for new treatment development in HD. The long-term goal of the proposed research is to identify biomarkers of difficulty discarding in HD and to develop treatments that engage those biomarkers. This is important because current treatments for HD are only modestly effective, with only a 35% response rate across studies. The short-term goal here is to determine the peripheral (PNS) and central nervous system (CNS) correlates of difficulty discarding behavior in HD and to distinguish these correlates from related psychopathology. The rationale for this goal is that by assessing PNS and CNS responses and the degree to which they are unique to HD and specifically to difficulty discarding, we will identify meaningful biomarker-based intervention targets. We will recruit 40 patients with primary HD, 40 clinical controls with anxiety disorders but not HD, and 40 healthy controls without psychiatric disorders. We will assess electrodermal, cardiac, and neural (EEG) activity during a series of discarding-relevant and emotionally neutral (discarding-irrelevant) tasks. Our central hypothesis is that patients with HD will demonstrate greater psychophysiological arousal and error related negativity during the discarding-relevant task than will anxious and healthy control participants. The proposed study will pursue the following specific aims: 1) determine the PNS and CNS correlates of difficulty discarding by comparing PNS and CNS activity during the discarding and neutral tasks; 2) determine the causal relationship between PNS and CNS activity and discarding behavior; and 3) determine whether PNS and CNS correlates of difficulty discarding are present to a greater degree in HD relative to other psychopathology. Our approach is innovative because it uses multilevel analysis and will examine, for the first time, the immediate CNS effects of discarding decisions in clinical HD participants. Our focus on the neurobiological mechanisms of HD is significant, as HD is a common and poorly treated condition and the proposed study will have direct implications for biomarker- informed novel treatment development.
在我们对困难的潜在神经生物学机制的理解上存在着一个关键的差距 丢弃,囤积症(HD)的核心行为特征。这一差距代表了一个重要问题 因为,在填满之前,该领域将无法精确识别新治疗的机制目标 HD的发展。拟议研究的长期目标是确定困难的生物标志物 在HD中丢弃并开发利用这些生物标志物的治疗方法。这一点很重要,因为目前 HD的治疗仅适度有效,在所有研究中仅有35%的应答率。短期 这里的目标是确定外周(PNS)和中枢神经系统(CNS)相关的困难 丢弃HD中的行为,并将这些相关性与相关的精神病理学区分开来。的理由 这一目标是通过评估PNS和CNS反应及其在HD中的独特程度, 具体到难以丢弃,我们将确定有意义的基于生物标志物的干预目标。我们将 招募40例原发性HD患者,40例焦虑症但非HD的临床对照,以及40例健康 对照组无精神疾病。我们将评估皮肤电、心脏和神经(EEG)活动, 一系列与情绪无关的任务。我们的核心假设是 HD患者在治疗期间将表现出更大的心理生理唤醒和错误相关的消极性, 与焦虑和健康的对照组相比,拟议的研究将继续 具体目的如下:1)通过比较,确定PNS和CNS与难弃性的相关性 在丢弃和中性任务期间PNS和CNS活动; 2)确定 PNS和CNS活性和丢弃行为;以及3)确定PNS和CNS是否与困难相关 相对于其他精神病理学,丢弃在HD中存在更大程度。我们的方法是创新的 因为它使用多层次分析,并将首次检查丢弃的直接CNS影响, 临床HD参与者的决策。我们对HD的神经生物学机制的关注是重要的,因为HD 是一种常见且治疗不良的疾病,拟议的研究将对生物标志物产生直接影响- 告知新的治疗开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Charles McPartland其他文献

James Charles McPartland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Charles McPartland', 18)}}的其他基金

Central and Peripheral Nervous System Correlates of Difficulty Discarding in Hoarding Disorder
中枢和周围神经系统与囤积症中丢弃困难的相关性
  • 批准号:
    10024084
  • 财政年份:
    2019
  • 资助金额:
    $ 21.21万
  • 项目类别:
Adapting Biomarker Assays for Individuals with Autism and Intellectual Disability
针对自闭症和智力障碍患者调整生物标志物检测
  • 批准号:
    10021720
  • 财政年份:
    2019
  • 资助金额:
    $ 21.21万
  • 项目类别:
Adapting Biomarker Assays for Individuals with Autism and Intellectual Disability
针对自闭症和智力障碍患者调整生物标志物检测
  • 批准号:
    9917304
  • 财政年份:
    2019
  • 资助金额:
    $ 21.21万
  • 项目类别:
Multimodel Assessment of Social Process Systems across Neurodevelopmental Disorders
跨神经发育障碍的社会过程系统的多模型评估
  • 批准号:
    9109048
  • 财政年份:
    2015
  • 资助金额:
    $ 21.21万
  • 项目类别:
The Autism Biomarkers Consortium for Clinical Trials
自闭症临床试验生物标志物联盟
  • 批准号:
    8984979
  • 财政年份:
    2015
  • 资助金额:
    $ 21.21万
  • 项目类别:
The Autism Biomarkers Consortium for Clinical Trials
自闭症临床试验生物标志物联盟
  • 批准号:
    9331734
  • 财政年份:
    2015
  • 资助金额:
    $ 21.21万
  • 项目类别:
5/5-The Autism Biomarkers Consortium for Clinical Trials
5/5-自闭症生物标志物临床试验联盟
  • 批准号:
    10083892
  • 财政年份:
    2015
  • 资助金额:
    $ 21.21万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10083885
  • 财政年份:
    2015
  • 资助金额:
    $ 21.21万
  • 项目类别:
The Autism Biomarkers Consortium for Clinical Trials
自闭症临床试验生物标志物联盟
  • 批准号:
    9901801
  • 财政年份:
    2015
  • 资助金额:
    $ 21.21万
  • 项目类别:
The Autism Biomarkers Consortium for Clinical Trials
自闭症临床试验生物标志物联盟
  • 批准号:
    10224931
  • 财政年份:
    2015
  • 资助金额:
    $ 21.21万
  • 项目类别:

相似海外基金

Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 21.21万
  • 项目类别:
    Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
  • 批准号:
    10677075
  • 财政年份:
    2023
  • 资助金额:
    $ 21.21万
  • 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
  • 批准号:
    478121
  • 财政年份:
    2023
  • 资助金额:
    $ 21.21万
  • 项目类别:
    Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
  • 批准号:
    10861961
  • 财政年份:
    2023
  • 资助金额:
    $ 21.21万
  • 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
  • 批准号:
    22KJ3164
  • 财政年份:
    2023
  • 资助金额:
    $ 21.21万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
  • 批准号:
    10685283
  • 财政年份:
    2022
  • 资助金额:
    $ 21.21万
  • 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
  • 批准号:
    10042996
  • 财政年份:
    2022
  • 资助金额:
    $ 21.21万
  • 项目类别:
    Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
  • 批准号:
    10705005
  • 财政年份:
    2022
  • 资助金额:
    $ 21.21万
  • 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
  • 批准号:
    10597521
  • 财政年份:
    2022
  • 资助金额:
    $ 21.21万
  • 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
  • 批准号:
    10573948
  • 财政年份:
    2022
  • 资助金额:
    $ 21.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了